2022 annual financial data
Aligos Therapeutics 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -570.86%.
Operating income was -97,580,000 USD and net income was -96,046,000 USD.
Operating cash flow was -79,389,000 USD.
Get free Aligos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,907,000 USD
- Operating income
- -97,580,000 USD
- Net income
- -96,046,000 USD
- Operating cash flow
- -79,389,000 USD